A-FABP Concentration Is More Strongly Associated with Cardiometabolic Risk Factors and the Occurrence of Metabolic Syndrome in Premenopausal Than in Postmenopausal Middle-Aged Women
Table 3
Pearson correlation coefficients between log A-FABP and measured parameters in pre- and postmenopausal women.
Log A-FABP PRE
Log A-FABP POST
PRE versus POST
Age
0.21*
0.08
0.37
BMI
0.63#
0.56#
0.46
WC
0.53#
0.47#
0.59
log glucose
0.27*
0.12
0.29
log insulin
0.42#
0.27*
0.25
log HOMA-IR
0.44#
0.29!
0.24
TC
0.15
0.11
0.78
LDL-C
0.20*
−0.08
0.06
HDL-C
−0.43#
−0.34!
0.48
TC/HDL-C
0.57#
0.19
0.003
log TG
0.35#
0.23!
0.38
log TG/HDL-C
0.45#
0.29!
0.21
log CRP
0.45#
0.36#
0.47
log FSH
−0.02
−0.27*
0.08
log E2
−0.25*
−0.07
0.21
SBP
0.31!
0.04
0.06
DBP
0.25*
0.02
0.011
log adiponectin
−0.30!
−0.28!
0.88
log DHEAS
0.09
−0.18
0.54
log SHBG
−0.32#
−0.26*
0.66
Number of MetS components
0.54#
0.29!
0.04
log 10-year ASCVD risk
0.39#
0.18
0.12
; ; ; premenopausal women (PRE); postmenopausal women (POST). Comparison of correlation coefficients PRE versus POST ().
